Skip to content

Nexfin monitoring and laboratory testing in the per-and postoperative setting of major hepatectomy

Nexfin monitoring and laboratory testing in the per-and postoperative setting of major hepatectomy - NeMo study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41251
Enrollment
15
Registered
2013-04-12
Start date
2013-10-03
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vochthouding in het lichaam tijdens en na een leverresectie decompensatio cordis overvulling

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients who will undergo a major hepatectomy

Exclusion criteria

Exclusion criteria: cirrhosis, renal failure, cardiac failure and cardiac arrythmias

Design outcomes

Primary

MeasureTime frame
Preoperative * Weight * Nexfin parameters: Stroke volume, cardiac output and cardiac index * 2x 24-hours urine sample for sodium, potassium and creatine excretion * 1x plasma sample antidiuretic hormone, aldosterone and renin Intraoperative * Fluid responsiveness after 250 ml fluid administration * Nexfin monitoring * Fluid balance and amount of fluids administered (ml.kg-1.h-1) Postoperative * 3 times a day Nexfin parameters: Stroke Volume, Cardiac Output and Cardiac index. The first measurement is in the morning before mobilization and after 2 minutes mobilization (out of bed; standing of sitting on a chair). * Daily body weight and ankle & abdominal girth * 2x 24-hour urine sample with sodium, potassium and creatine excretion * First 5 days at the ward: daily measurement of electrolytes sodium, potassium, bicarbonate and chloride. * Daily measurements of plasma concentrations aldosterone, renin and antidiuretic hormone will be done before mobilization and after 20 minutes mobilization.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)